---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-005216"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2023-02-15T23:59:59+00:00"
generated_at: "2026-06-19T11:43:26.273224+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions Q2 net loss narrows to $0.42M; govt support income up 52%

## Summary
- Net loss of $0.42M ($0.46/shr) vs $3.46M ($4.65/shr) in prior year period.
- Government support income rose 52% to $269,625 on R&D qualifying expenditures.
- Cash and equivalents $2.9M at quarter-end; successful completion of Milestone 7 biosensor phase.
- Milestone 7 achieved 4x improvement in time-to-result, enabling under-one-minute test.
- Partnered with Boughey Distribution and Hozelock for fingerprint drug testing programs.

## SEC filing metadata
- accession: 0001493152-23-005216
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2023-02-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315223005216/0001493152-23-005216-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315223005216/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-005216
- JSON: https://secwatch.observer/filing/0001493152-23-005216.json
- Plain text: https://secwatch.observer/filing/0001493152-23-005216.txt

## Key facts
- Earnings Releases
  INTELLIGENT BIO SOLUTIONS INC. reported fiscal second quarter ended December 31, 2022 results: net income $0.42 million or $0.46 per share, EPS $0.46 per share.
  - Period: fiscal second quarter ended December 31, 2022
  - Net income: $0.42 million or $0.46 per share
  - EPS: $0.46 per share
  - Result: reported results
  source text: For the quarter that ended December 31, 2022, the Company had a net loss of $0.42 million or $0.46 per share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315223005216/0001493152-23-005216-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.